Nyxoah SA Ordinary Shares (NYXH) is a publicly traded Healthcare sector company. As of October 15, 2026, NYXH trades at $1.20 with a market cap of $127.30M and a P/E ratio of 0.00. NYXH moved -4.40% today. Year to date, NYXH is -73.56%; over the trailing twelve months it is -80.46%. Its 52-week range spans $1.19 to $11.87. Analyst consensus is buy with an average price target of $4.26. Rallies surfaces NYXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover NYXH: 0 strong buy, 3 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.26.
| Metric | Value |
|---|---|
| Price | $1.20 |
| Market Cap | $127.30M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.87 |
| 52-Week Low | $1.19 |
| Volume | 26.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover NYXH: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.26.